Evidence map›Paper›PMID 26587549›Full record

ArticleJournal of medical imaging (Bellingham, Wash.)2015

Core samples for radiomics features that are insensitive to tumor segmentation: method and pilot study using CT images of hepatocellular carcinoma.

Sebastian Echegaray, Olivier Gevaert, Rajesh Shah, Aya Kamaya, John Louie, Nishita Kothary, Sandy Napel

Abstract read
In one paragraph

Article in Journal of medical imaging (Bellingham, Wash.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. [Research progress of radiomics with artificial intelligence in precise diagnosis and treatment of hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2020
    Article
  13. The application of texture quantification in hepatocellular carcinoma using CT and MRI: a review of perspectives and challenges.Cancer imaging : the official publication of the International Cancer Imaging Society · 2020
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sebastian EchegarayStanford University , Department of Electrical Engineering, 650 Serra Mall, Stanford, California 94305, United States.
Olivier GevaertStanford University , Department of Radiology, 650 Serra Mall, Stanford, California 94305, United States.
Rajesh ShahStanford University , Department of Radiology, 650 Serra Mall, Stanford, California 94305, United States.
Aya KamayaStanford University , Department of Radiology, 650 Serra Mall, Stanford, California 94305, United States.
John LouieStanford University , Department of Radiology, 650 Serra Mall, Stanford, California 94305, United States.
Nishita KotharyStanford University , Department of Radiology, 650 Serra Mall, Stanford, California 94305, United States.
Sandy NapelStanford University , Department of Radiology, 650 Serra Mall, Stanford, California 94305, United States.

Funding

Qualification and Deployment of Imaging Biomarkers of Cancer Treatment ResponseU01CA190214 · NCI · STANFORD UNIVERSITY · PI RUBIN, DANIEL L · 2015 to 2020
$3.1M
Tools for Linking and Mining image and Genomic Data in Non-Small Cell Lung CancerR01CA160251 · NCI · STANFORD UNIVERSITY · PI NAPEL, SANDY A., PLEVRITIS, SYLVIA KATINA · 2011 to 2015
$2.9M
Computing, Optimizing, and Evaluating Quantitative Cancer Imaging BiomarkersU01CA187947 · NCI · STANFORD UNIVERSITY · PI NAPEL, SANDY A., RUBIN, DANIEL L · 2015 to 2019
$2.9M
Computerized Quantitative Imaging Assessment of Tumor BurdenU01CA142555 · NCI · STANFORD UNIVERSITY · PI RUBIN, DANIEL L · 2010 to 2014
$2.9M
Radiogenomics Framework for Non-Invasive Personalized MedicineR01EB020527 · NIBIB · STANFORD UNIVERSITY · PI GEVAERT, OLIVIER · 2015 to 2018
$2.3M
NCI NIH HHS R01 CA160251NCI NIH HHS U01 CA142555NCI NIH HHS U01 CA187947NCI NIH HHS U01 CA190214NIBIB NIH HHS R01 EB020527
6 · The paper itself

Abstract

The purpose of this study is to investigate the utility of obtaining "core samples" of regions in CT volume scans for extraction of radiomic features. We asked four readers to outline tumors in three representative slices from each phase of multiphasic liver CT images taken from 29 patients (1128 segmentations) with hepatocellular carcinoma. Core samples were obtained by automatically tracing the maximal circle inscribed in the outlines. Image features describing the intensity, texture, shape, and margin were used to describe the segmented lesion. We calculated the intraclass correlation between the features extracted from the readers' segmentations and their core samples to characterize robustness to segmentation between readers, and between human-based segmentation and core sampling. We conclude that despite the high interreader variability in manually delineating the tumor (average overlap of 43% across all readers), certain features such as intensity and texture features are robust to segmentation. More importantly, this same subset of features can be obtained from the core samples, providing as much information as detailed segmentation while being simpler and faster to obtain.

Indexed as

CThepatocellular carcinomaimage featuresradiomicssegmentationstability

Identifiers

PMID26587549
PMCPMC4650964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.